Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study
- 22 December 2009
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 16 (2), 238-247
- https://doi.org/10.1177/1352458509354551
Abstract
Background: poor sleep is common in MS and it contributes to fatigue. The β interferons produce systemic effects which may not adapt and may induce fatigue. Objective: to verify whether subjective poor sleep and fatigue during chronic therapy correspond to reduced sleep efficiency obtained by actigraphy at home. Methods: 42 ambulatory relapsing remitting MS patients with mild disability were monitored for at least 7 nights. Habitual sleep quality and fatigue were assessed with the MOS sleep measure and the Fatigue Severity Scale. Sleep logs provided daily sleep quality assessments during actigraphy at home. Patients were grouped according to their current treatment: no therapy, glatiramer acetate, IFNβ 3 times a week, and IFNβ once a week. Results and Conclusion: sleep efficiency was reduced by an average of 5% in 2/3 of the nights following IFNβ injections compared to the other nights, and daily sleep ratings correlated with actigraphy. Patients on glatiramer acetate also showed a lower sleep efficiency than patients without therapy. Actigraphy data were only modestly correlated with MOSsm scores, not with fatigue. Long term adaptation of sleep effects of immunomodulant agents is incomplete and needs to be considered in treatment planning and assessment of sleep in MS.This publication has 33 references indexed in Scilit:
- Prevalence of ‘poor sleep’ among patients with multiple sclerosis: An independent predictor of mental and physical statusSleep Medicine, 2009
- Importance of sleep in the quality of life of multiple sclerosis patients: A long under-recognized issueSleep Medicine, 2009
- The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosisNeuroscience and Behavioral Physiology, 2008
- Prevalence of sleep problems in individuals with multiple sclerosisMultiple Sclerosis Journal, 2008
- Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damageMultiple Sclerosis Journal, 2008
- Time of interferon-β 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patientsMultiple Sclerosis Journal, 2007
- Sleep and fatigue in multiple sclerosisMultiple Sclerosis Journal, 2006
- Sleep Disorders in Multiple SclerosisSeminars in Neurology, 2005
- INTERFERON-α ACUTELY IMPAIRS SLEEP IN HEALTHY HUMANSCytokine, 2000
- Nocturnal sleep study in multiple sclerosis: Correlations with clinical and brain magnetic resonance imaging findingsJournal of the Neurological Sciences, 1994